Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
The purpose of this study is to test feasibility, toxicity and efficacy of two different adjuvant treatment schedules in Stage II-IIIa Non-small cell lung cancer patients with positive lymph nodes.
Non-Small Cell Lung Cancer
DRUG: gemcitabine|DRUG: cisplatin|PROCEDURE: radical surgery|PROCEDURE: chemoradiotherapy
2-year overall survival
Toxicity assessment|Assessment of feasibility of two treatment orders|Clinical and pathological response rate to neoadjuvant chemotherapy|Disease free survival
The purpose of this study is to test feasibility, toxicity and efficacy of two different adjuvant treatment schedules in Stage II-IIIa Non-small cell lung cancer patients with positive lymph nodes.